The world's first preventative breast cancer vaccine is one step closer to human trials.
The Tuohy vaccine was announced last October by Dr. Vince Tuohy at the Cleveland Clinic. Five women then formed a coalition called the Champions of the Pink Vaccine to help get the word out.
The vaccine proved effective and safe in three different animal trials and the only thing standing in the way of asking for FDA approval for human trials was money.
Tuesday Judy Fitzgerald was visiting her sons at Notre Dame, called NewsCenter 16 to say the money has been raised.
And the Cleveland Clinic created a spin-off company, Shield Biotech, to seek FDA approval for human trials. She says now we need people nationwide to ask the FDA to support the effort.
All involved believe this vaccine may, like polio and measles, one day eradicate breast cancer.
"Getting money for the trial has really been the biggest obstacle and now that we have that this is incredible news,” says Judy Fitzgerald. “The mere chance that breast cancer can be a thing of the past is just something that once was imaginable. I actually was at the grotto three weeks ago and said a prayer. I think Mary had a hand in this but I just want to thank you personally Maureen because you were a key factor in us getting support for the vaccine. I am just over the moon.”
You may wonder how NewsCenter 16 helped. Our story was also aired by our affiliates nationwide and Judy says it really raised attention about the vaccine in Cleveland.
Champions of the Pink Vaccine: